CClinicalTrials.gg
RecruitingNCT05179655Updated Mar 10, 2025

TEENS Multi-site Trial

An interventional study of Emotion Regulation Individual Therapy for Adolescents (ERITA) and Treatment as usual in Self-Injurious Behavior, sponsored by Mental Health Services in the Capital Region, Denmark. Recruiting at 4 sites in Denmark. Open to participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-03-10.

Sponsored by Mental Health Services in the Capital Region, Denmark · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
356
Allocation
Randomized
Ages
13 Years to 17 Years
Sex
All
01

Study summary

Emotion Regulation Individual Therapy for Adolescents, also called ERITA, is a youth friendly online therapy aiming to provide skills and train emotion regulation.

The aim of the TEENS Multi-site Trial is to investigate the effect of ERITA, including an app, as add-on to treatment as usual in young patients referred to Mental Health Services. We expect 356 families to participate from three designated Regions in Denmark.

Read the detailed description

Background: A prevalence of non-suicidal self-injury is not easily assessed; however, meta-analyses found a lifetime prevalence of 17% in non-clinical student samples. This estimate increases to 50-74% in psychiatric populations. Non-suicidal self-injury is an important predictor for later suicidal behavior and death by suicide. Although non-suicidal self-injury is highly prevalent, there is no evidence for specific treatment for non-suicidal self-injury in adolescents. Reviews find that internet-based interventions guided by a therapist are effective for several psychiatric disorders such as anxiety and depression in adult population. Patients with stigmatizing illnesses such as non-suicidal self-injury may be reluctant to seek help and adhere with treatment while internet-based interventions are more appealing. There is a need for trials investigating the effect of specialized interventions for non-suicidal self-injury in youth, including digital interventions.

Objective: To investigate the effect of an internet-based intervention, Emotion Regulation Individual Therapy for Adolescents (ERITA), as add-on to treatment as usual in 13-17-year-old patients with non-suicidal self-injury referred to Child- and Adolescent Mental Health Services with subsequent non-suicidal self-injury as primary outcome assessed by Deliberate Self-Harm Inventory - Youth. Further clinical outcomes such as quality of life, depression, anxiety and stress, as well as emotion regulation difficulties will be assessed as secondary outcomes.

Method and materials: This is a randomized, clinical, superiority, multicenter trial in a parallel group design. Patients will be recruited from Child- and Adolescent Mental Health Services in three of the Danish Regions: The trial inclusion period will be from primo 2022 to ultimo 2023. The experimental intervention is therapist guided internet-based ERITA provided exclusively online as add-on to treatment as usual in the experimental group. Treatment as usual is provided by multidisciplinary teams in outpatient clinics in all participating regions. We expect to include 356 participants and one of their parents.

02

Conditions studied

  • Self-Injurious Behavior

Keywords

  • Internet-based intervention
  • Online therapy
  • Emotion regulation
  • ERITA
03

Who can participate

Ages eligible
13 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ≥ 5 non-suicidal self-injury episodes in the past year and ≥ 1 non-suicidal self-injury episodes in the past month assessed by the Deliberate Self-Harm Inventory, Youth version (DSHI-Y).
  • Age-appropriate literacy assessed by referring clinicians and the self-injury team, i.e. age between 13 and 17.
  • Having at least one parent committing to participate in the parent program.
  • Informed consent from parents/legal caretakers and assent from participants above 15 years of age.

Exclusion criteria

Exclusion Criteria:

  • Imminent suicidal risk assessed by clinicians during routine screening procedure (that can be rated as no risk, elevated risk, or imminent risk) in need of admission or other life saving strategies.
  • Lack of informed consent from parents/legal caretakers.
  • Lack of informed assent from the participant above 15 years of age.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
356 participants (estimated)

Study arms

  • Experimental
    ERITA + TAU (Treatment as usual)

    The Emotion Regulation Individual Therapy for Adolescents (ERITA) intervention as add-on to TAU consists of 11 weeks, manualized online therapy based on the methods of Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and Acceptance and Commitment Therapy (ACT) adapted for youth

    Behavioral: Emotion Regulation Individual Therapy for Adolescents (ERITA) · Other: Treatment as usual

  • Other
    TAU (Treatment as usual)

    Within mental health services in Denmark child and adolescent psychiatrists provide specialized treatment for young psychiatric patients as outpatient services. In this study the control intervention (TAU) consists of clinical assessment and treatment for patient's current primary psychiatric condition (referral condition and A-diagnosis).

    Other: Treatment as usual

Interventions

  • BehavioralEmotion Regulation Individual Therapy for Adolescents (ERITA)

    The ERITA intervention as add-on to TAU consists of 11 weeks, manualized online therapy based on the methods of Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and Acceptance and Commitment Therapy (ACT) adapted for youth. The ERITA content consists of psychoeducation, emotion recognition, awareness training and theory of emotion regulation, including acceptance and validation skills.

    Also known as: ERITA

  • OtherTreatment as usual

    Within Mental Health Services in Denmark child and adolescent psychiatrists provide specialized treatment for young psychiatric patients as outpatient services. In this trial the control intervention is treatment as usual (TAU) and consists of clinical assessment and treatment for patient's current primary psychiatric condition. TAU encounters a variety of clinical treatment and assessment offers, however, all within the field of expertise in child and adolescent psychiatry; out-patient care may consist of treatment for OCD, eating disorders, psychoses or affective disorders. TAU may consist of pharmacological treatment, Family-Based Treatment (FBT), Cognitive Behavioral Therapy (CBT), supportive counselling and/or psychoeducation.

05

What researchers measure

Primary outcomes

  1. Non-suicidal self-injury episodes

    Non-suicidal self-injury within the last four weeks, at end of intervention (12 weeks) by blinded outcome assessment by phone or video conference measured by Deliberate Self-Harm Inventory

    Time frame: End of treatment after 12 weeks and 6 months follow-up

Secondary outcomes

  1. Kidscreen-10; Quality of life

    Quality of life at 12 weeks, assessed with Kidscreen-10, a five point likert scale, range: not at all, a little, moderate, much, very much.

    Time frame: End of treatment after 12 weeks and 6 months follow-up

  2. Symptoms of depression, anxiety and stress

    Symptoms of depression, anxiety and stress at 12 weeks, assessed with Depression Anxiety Stress Scale (DASS-21) presented as analyses for each subgroup item. Four point likert scale, range: did not apply to me, applied to me to some degree, applied to me to a considerable degree, applied to me much/most of the time. Total rage for subscores: 0-42. Higher scores reflect worse outcome.

    Time frame: End of treatment after 12 weeks and 6 months follow-up

  3. Non-suicidal self-injury as dichotomous (any/none)

    The proportion of participants with any NSSI during the past four weeks.

    Time frame: End of treatment after 12 weeks and 6 months follow-up

Other outcomes

  1. Difficulties in emotion regulation

    Difficulties in emotion regulation, assessed with Difficulties in Emotion Regulation Scale - 16 Item Version (DERS-16). DERS-16 has 16 items which each generates a score from 1 to 5. The results will be presented as one sum-score. The scores in this scale range from 16-80 with higher scores indicating greater emotion regulation difficulties.

    Time frame: End of treatment after 12 weeks and 6 months follow-up

  2. Borderline Symptom List (BSL-supplement).

    Indirect self-destructive behaviours assessed with Borderline Symptom List (BSL-supplement). BSL-supplement has 11 items which each generates a score from 0 to 4. The results will be presented as one sum-score.

    Time frame: Through trial periode (every three weeks, end of treatment after 12 weeks and 6 months follow-up)

  3. Suicidal ideations

    Suicidal ideations assessed by SIDAS. A five item scale with questions ranging from 0 to 10. Final sum score from 0-50.

    Time frame: Through trial period (every three weeks, end of treatment after 12 weeks and 6 months follow-up)

  4. Coping with Children's Negative Emotions - Adolescents

    Adolescent rated parents' ability to cope with children's negative emotions assessed with The Coping with Children's Negative Emotions Scale (CCNES-APP). 9 main items with 6 sub items (a to f) for each. Each sub item generates a score from 1 to 7. The results will be presented as mean-scores for the six subscales.

    Time frame: End of treatment after 12 weeks and 6 months follow-up

  5. Coping with Children's Negative Emotions - Parents

    Parent-rated perceived ability to cope with children's negative emotions assessed with The Coping with Children's Negative Emotions Scale Adolescent (CCNES-A). 9 main items with 6 sub items (a to f) for each. Each sub item generates a score from 1 to 7. The results will be presented as mean-scores for the six subscales.

    Time frame: End of treatment after 12 weeks and 6 months follow-up

  6. Negative Effects Questionnaire

    Adverse Events of therapy assessed with Negative Effects Questionnaire (NEQ). NEQ has 20 items, with 5 sub-items The results will be presented as means and standard deviations.

    Time frame: Through trial periode (every three weeks and end of treatment after 12 weeks)

  7. Working Alliance

    The alliance percieved between the participant and the therapist, WAI-SR

    Time frame: Through the trial period (week four and eight)

06

Study locations

2 of 4 sites recruiting
  • Child and Adolescent Mental Health Services
    Aalborg, 9000, Denmark
    Not yet recruiting
  • Team for Self-injury, Child and Adolescent Mental Health Services, B195
    Copenhagen, 2100, Denmark
    Recruiting
  • Child and Adolescent Mental Health Services Southern Region Denmark
    Odense, 5000, Denmark
    Recruiting
  • Child and Adolescent Mental Health Services in Region Zealand
    Roskilde, 4000, Denmark
    Not yet recruiting
07

Registry details

Key details

Study ID
NCT05179655
Lead sponsor
Mental Health Services in the Capital Region, Denmark
Collaborators
Copenhagen Trial Unit, Center for Clinical Intervention Research, Region of Southern Denmark, Region Zealand
Responsible party
Britt Reuter Morthorst (Associate Professor, Senior researcher, Mental Health Services in the Capital Region, Denmark) — Principal investigator
First posted
Jan 5, 2022
Start date
Feb 1, 2022
Primary completion
May 15, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 10, 2025

Study contacts

Britt Morthorst
Contact
britt.reuter.morthorst@regionh.dk
0045 27521085
Anne K Pagsberg, Professor
study chair · Mental Health Services Capital Region Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion